Defining the roles and therapeutic potential of C-type natriuretic peptide in the cardiac and vascular dysfunction underpinning heart failure with preserved ejection fraction
British Heart Foundation
· United Kingdom · £9.52M GBP
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.